Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71072de80db00a0aac2545fc20c7f8f6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a07bc18321957d79ca82e090e0a93cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03f6e32b676b446e0bd0caf3dc5b4d5d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac8c96626cb1f1d5cb6003c42bc420fe http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a36f4033db85f98099fb0f4442ac63a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76f4d24bbb0e284c6a72db9f3d912bae |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2871 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1754 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2012-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69368ab181d06f7979562eb7cc726293 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99f5958003150a845fa4e36eb8f6c573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0157508b6fc9597e1e83553c784c945f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c65d748237fd58b8dc4cebc110f8bf9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dff431c8ace48db45f548b9f13bff6ae |
publicationDate |
2012-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2012140327-A1 |
titleOfInvention |
Method for determining the risk of cardiovascular events using igfbp fragments |
abstract |
The present invention describes the method for determining the risk of future major adverse cardiovascular events, which comprises detection proteolytic fragments of IGFBP-4 or IGFBP-5 (insulin-like growth factor binding protein 4 or insulin-like growth factor binding protein 5) in patients' blood. The present invention provides antibodies and immunoas- says, suitable for specific measurement of proteolytic fragments of IGFBPs. In current invention the IGFBP fragments are suggested to be utilized as blood biomarkers for the risk prediction of major adverse cardiovascular events (MACE). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104515860-A |
priorityDate |
2011-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |